By integrating bulk and single-cell transcriptomic analyses complemented by immunohistochemical validation, study demonstrated that GZMB and SPP1 contribute to an immunosuppressive TME and are significantly associated with resistance to NAT and poor prognosis in IBC. This evidence concerns the gene BRD2 and inflammatory breast carcinoma.